Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 140Lung Neoplasms 84Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 36Head and Neck Neoplasms 34Colonic Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 33Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Melanoma 19Hematologic Neoplasms 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Papillomavirus Infections 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Interventions

folfirinox 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Resectable Pancreatic Cancer × Clear all
NCT04472910 2026-03-12

NeoPancOne

University Health Network, Toronto

Phase NA Active not recruiting
84 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡